Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kindstar Globalgene Technology, Inc. ( (HK:9960) ) just unveiled an announcement.
Kindstar Globalgene Technology, Inc. has completed the acquisition of equity interests in two target companies, enhancing its strategic positioning and expanding its operational capabilities. The completion of these acquisitions involves the issuance of shares to Wuxi Anchor and OrbiMed, reflecting the company’s commitment to growth and increased stakeholder value.
More about Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. operates in the biotechnology industry and is incorporated in the Cayman Islands. The company focuses on acquiring equity interests in other companies, aiming to consolidate its market position and expand its operations across different regions.
YTD Price Performance: -5.93%
Average Trading Volume: 571,423
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$1.09B
Learn more about 9960 stock on TipRanks’ Stock Analysis page.